Mediclinic Middle East Joins Hub71+ Life Sciences to Advance Healthcare Innovation
A transformative partnership between a leading healthcare provider and Abu Dhabi's premier technology ecosystem will foster the development of pioneering medical technologies and strengthen the emirate's position as a global centre for healthcare innovation.
Mediclinic Middle East has formalised a strategic partnership with Hub71, Abu Dhabi’s globally recognised technology ecosystem, through a Memorandum of Understanding signed during the Abu Dhabi Future Health Summit 2026. This collaboration marks a significant milestone in positioning Abu Dhabi as a nexus for healthcare innovation and technological advancement.
The partnership establishes Mediclinic Middle East within the Hub71+ Life Sciences specialist ecosystem, creating a distinctive confluence of clinical expertise and entrepreneurial dynamism. Through this alliance, HealthTech startups gain access to invaluable clinical insights and real-world healthcare knowledge, whilst Mediclinic Middle East gains visibility into emerging technologies that align with its evolving healthcare priorities.
Mediclinic Middle East will engage directly with innovators developing healthcare technologies, offering mentorship, clinical guidance and strategic direction to help founders refine their solutions and explore meaningful applications within clinical environments. This collaborative framework enables startups to validate their innovations in real-world settings, with direct input from experienced healthcare professionals.
The partnership encompasses a comprehensive range of clinical focus areas, including cancer care, fertility and IVF services, musculoskeletal services, chronic disease management, women’s health, care delivery beyond traditional hospital settings, virtual care capabilities and clinical augmentation technologies.
Hein van Eck, Chief Executive Officer of Mediclinic Middle East, expressed the significance of this collaboration, emphasising that innovation’s true value emerges when it demonstrably improves patient outcomes. He noted that by combining clinical expertise with entrepreneurial vision, the partnership creates authentic opportunities for healthcare technologies to address genuine clinical challenges whilst supporting Abu Dhabi’s expanding life sciences and healthcare innovation sector.
Basma AlBadi AlDhaheri, Head of Growth and Value Creation at Hub71, highlighted the transformative potential of connecting startups with established industry partners. She emphasised that this partnership effectively bridges the distance between innovation and practical implementation, enabling entrepreneurs to develop, rigorously test and bring novel healthcare solutions to market with confidence and credibility.
As part of the Hub71+ Life Sciences ecosystem, Mediclinic Middle East will contribute substantially to mentorship initiatives and knowledge-sharing activities, enriching the learning environment for startups and reinforcing Abu Dhabi’s commitment to fostering a thriving healthcare innovation community.
Source: WAM